Novel EG95-based mRNA vaccines induce long-term protective immunity against echinococcosis
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014659 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Wei-Gang Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, National Professional Laboratory f…. Hauptthemen laut MEDLINE: Echinococcosis, Antigens, Helminth, Helminth Proteins, Echinococcus granulosus. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, The Major Science and Technology Project of Gansu Province, Gansu Province Joint Research Fund.
Abstract (Originalsprache)
Cystic echinococcosis (CE), a neglected zoonotic disease caused by Echinococcus granulosus sensu lato , remains a significant public health and veterinary concern worldwide. Despite efforts to develop recombinant protein-based vaccines against EG95, a key protective antigen, existing platforms suffer from limited immunogenicity, short-lived immunity, and complex production processes. Here, we designed and evaluated three novel mRNA-LNP vaccines, including EG95 mRNA-LNP vaccine, IL-4-EG95 mRNA-LNP vaccine encoding EG95 fused with IL-4 via a flexible linker to enhance immune stimulation, and EG95-EC95 mRNA-LNP vaccine that multivalent formulation incorporating EC95 antigens from Echinococcus canadensis . The vaccine candidates were efficiently encapsulated in lipid nanoparticles and demonstrated robust target expression in vitro and in vivo. Immunization induced significantly stronger, more durable humoral and cellular immune responses compared to a commercial EG95 subunit vaccine both in mice and lambs. Notably, high levels of specific antibodies persisted for over 12 months post-vaccination. Parasites infection challenge experiments confirmed that these three mRNA-LNP vaccines, especially the IL-4-EG95 vaccine conferred superior protection, inhibited protoscolex survival and cyst growth. These results highlight the advantages of mRNA-based vaccines in safety, scalability, and flexibility over conventional approaches, offering a promising strategy for controlling E. granulosus sensu lato transmission and reducing the zoonotic burden of CE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, National Professional Laboratory for Animal Echinococcosis, Gansu Province Research Center for Basic Dis…
- Key Laboratory of Animal Parasitology, Ministry of Agriculture/ Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
- Huangyuan County Animal Husbandry and Veterinary Station, Xining, Qinghai Province, China.
- Animal Science Department, Qinghai Agricultural and Animal Husbandry Technology Vocational College, Xining, Qinghai Province, China.
- Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Disease, Yangzhou, Jiangsu Province, China.
ORCID-Profile: Wei-Gang Chen
Förderung
- National Key Research and Development Program
- The Major Science and Technology Project of Gansu Province
- Gansu Province Joint Research Fund
- Key Research and Development of Science and Technology Plan in Tibet Autonomous Region
- Innovation Program of Chinese Academy of Agricultural Sciences
- Key Laboratory of Agricultural Information Service Technology
- The Central Public-Interest Scientific Institution Basal Research Fund
- NBCITS
Zitieren
APA
Chen, W. G., Li, L., Dai, G. D., Wu, Y. D., Zhu, C. G., Zhang, H., Li, X. R., Li, L., Zhang, N. Z., Wang, L. Q., Li, G. C., Ma, W. L., Pan, J. T., Tan, M. L., Da, F. L., Yin, H., Fu, B. Q., Luo, X. N., Yan, H. B., & Jia, W. Z. (2026). Novel EG95-based mRNA vaccines induce long-term protective immunity against echinococcosis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014659
Vancouver
Chen WG, Li L, Dai GD, Wu YD, Zhu CG, Zhang H, et al. Novel EG95-based mRNA vaccines induce long-term protective immunity against echinococcosis. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014659
BibTeX
@article{Chen2026,
author = {Chen, Wei-Gang and Li, Li and Dai, Guo-Dong and Wu, Yao-Dong and Zhu, Chuan-Gang and Zhang, Huan and Li, Xiu-Rong and Li, Le and Zhang, Nian-Zhang and Wang, Li-Qun and Li, Guo-Cai and Ma, Wen-Ling and Pan, Ji-Tao and Tan, Ming-Lu and Da, Fu-Lan and Yin, Hong and Fu, Bao-Quan and Luo, Xue-Nong and Yan, Hong-Bin and Jia, Wan-Zhong},
title = {Novel EG95-based mRNA vaccines induce long-term protective immunity against echinococcosis},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014659}
}
EUVIMED